Anzeige
Mehr »
Login
Dienstag, 07.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Diese Aktie hebt ab: +130,67% Kursgewinn in 1 Monat – das sind die Gründe
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Übersicht Suchergebnisse zum Thema PROGRESSIVE

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
15:50Progressive Corporation-Aktie heute am Aktienmarkt gefragt (199,68 €)147Am US-amerikanischen Aktienmarkt liegt die Progressive Corporation-Aktie gegenwärtig im Plus. Zuletzt zahlten Investoren für das Papier 199,68 Euro. Heute hat sich im US-amerikanischen Wertpapierhandel...
► Artikel lesen
MoPROGRESSIVE CORP/OH/ - 10-Q, Quarterly Report2
FrNEXT Biometrics Group ASA: Progressive product milestone achieved - Tier one Chinese OEM customer to integrate NEXT's China ID sensor solution1
FrHere's Why Progressive (PGR) was 31% Up in Q11
FrParkMobile is the Official Parking Reservation Provider for the Cleveland Guardians at Progressive Field1
DoProgressive Planet Solutions Inc (2): Progressive Planet talks 28-day PozPyro test results1
DoProgressive Planet Announces Superb 28 Day Compressive Strength for New Low Carbon Cement1
30.04.Progressive Corporation: Progressive Announces Investor Relations Call4
30.04.Growing Progressive Set to Hire 10,000+ in Claims, IT, Other Roles 1
24.04.Cannabis Reform A Priority For Congressional Progressive Caucus And More News From South Carolina, Utah, Montana & Maine1
24.04.South Africa: Cosatu Applauds the Progressive Agreement to Halt Retrenchments of 6 000 Workers At the Post Office1
22.04.Progressive Care Inc. - 8-K, Current Report1
22.04.Progressive, Q2 Holdings And 2 Other Stocks Insiders Are Selling1
22.04.Progressive Gains as Drivers Shop Around for Auto Insurance-Again1
19.04.Progressive Familial Intrahepatic Cholestasis Treatment Market Projected to Reach $156.14 million by 2030 - Exclusive Report by 360iResearch359PUNE, India, April 18, 2024 /PRNewswire/ -- The report titled "Progressive Familial Intrahepatic Cholestasis Treatment Market by Drug Type (Cholestyramine, Rifampicin, Ursodeoxycholic Acid)...
► Artikel lesen
18.04.Roche reveals promising phase 3 results for subcutaneous Ocrevus in progressive and relapsing MS17
17.04.F. Hoffmann-La Roche Ltd: Roche's subcutaneous OCREVUS one-year data demonstrates near-complete suppression of clinical relapses and brain lesions in patients with progressive and relapsing forms of MS188Results from the Phase III study showed that subcutaneous (SC) injection was consistent with IV infusion and demonstrated near-complete suppression of relapse activity (97%) and MRI lesions (97.2%)...
► Artikel lesen
15.04.Where Progressive Stands With Analysts1
15.04.Severfield PLC - Progressive publish new research1
12.04.Progressive's Income Jumps as Insurer Adds More Policies1
Seite:  Weiter >>